Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Albumin Infusion Targets on Mortality in Patients With Abdominal Sepsis

NCT06874634 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.

NCT NCT06874634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06874634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Albumin Infusion Targets on Mortality in Patients With Abdominal Sepsis
Lead sponsor
Nanfang Hospital, Southern Medical University
Phase
Observational
Overall status
Completed
Start date
March 11, 2024
Completion date
January 30, 2025
Enrollment
180 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

28-day mortality